SUN Pharmaceutical Industries Limited — Clarithromycin Exporter Profile
Indian Pharmaceutical Exporter · #2 for Clarithromycin · $15.4M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #2 Indian exporter of Clarithromycin with $15.4M in export value and 309 verified shipments. SUN Pharmaceutical Industries Limited holds a 15.7% market share in Clarithromycin exports across 11 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Clarithromycin Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Clarithromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $5.5M | 232 | 68.1% |
| SOUTH AFRICA | $995.6K | 25 | 12.3% |
| CANADA | $597.1K | 21 | 7.4% |
| RUSSIA | $250.0K | 7 | 3.1% |
| UKRAINE | $216.5K | 9 | 2.7% |
| OMAN | $153.1K | 4 | 1.9% |
| CAMBODIA | $150.0K | 3 | 1.9% |
| THAILAND | $111.5K | 4 | 1.4% |
| KAZAKHSTAN | $100.0K | 2 | 1.2% |
| BRAZIL | $36 | 8 | 0.0% |
SUN Pharmaceutical Industries Limited exports Clarithromycin to 11 countries. The largest destination is BELGIUM accounting for 68.1% of SUN Pharmaceutical Industries Limited's Clarithromycin shipments, followed by SOUTH AFRICA (12.3%) and CANADA (7.4%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Clarithromycin from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $4.0M | 186 |
| YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN | BELGIUM | $919.2K | 27 |
| M/S. YUSEN LOGISTICS BENELUX BELGIU | BELGIUM | $581.6K | 19 |
| M/S. SUN PHARMA CANADA INC | CANADA | $348.5K | 12 |
| M/S. RANBAXY PHARMACEUTICALS PTY LT | SOUTH AFRICA | $300.0K | 6 |
| M S RANBAXY PHARMACETICALS PTY LTD | SOUTH AFRICA | $213.8K | 6 |
| LLC RANBAXY PHARMACEUTICALS UKRAINE | UKRAINE | $154.3K | 4 |
| RANBAXY (THAILAND) CO. LTD, | THAILAND | $111.5K | 4 |
| RANBAXY PHARMACEUTICALS PTY LIMITED | SOUTH AFRICA | $105.9K | 3 |
| MS SUN PHARMA CANADA INC | CANADA | $105.6K | 5 |
SUN Pharmaceutical Industries Limited supplies Clarithromycin to 38 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM) and M/S. YUSEN LOGISTICS BENELUX BELGIU (BELGIUM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Clarithromycin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $61.2M worth of Clarithromycin through 3,576 shipments from 334 suppliers to 144 countries, serving 811 buyers globally. SUN Pharmaceutical Industries Limited contributes $15.4M to this total, accounting for 15.7% of India's Clarithromycin exports. SUN Pharmaceutical Industries Limited ships Clarithromycin to 11 countries through 38 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Clarithromycin Exports?
SUN Pharmaceutical Industries Limited's average Clarithromycin shipment value is $50.0K per consignment, based on 309 shipments totaling $15.4M. The largest destination is BELGIUM (68.1% of SUN Pharmaceutical Industries Limited's Clarithromycin exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Clarithromycin Exporters?
SUN Pharmaceutical Industries Limited ranks #2 among 334 Indian Clarithromycin exporters with a 15.7% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($15.4M), MICRO LABS LIMITED ($15.4M), AUROBINDO PHARMA LTD ($7.8M). SUN Pharmaceutical Industries Limited processed 309 shipments to 11 destination countries.
What Clarithromycin Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CLARITHROMYCIN TABLETS 500MG PACK : 2x7 | $222.6K | 6 |
| CLARITHROMYCIN BASICS TAB 500MG PACK : 1 | $174.5K | 4 |
| KLABAX TABLETS 500MG PACK : 2X7 (S07) BATCH : DFF2156A, DFF2396A EACH FILM COATED CONTS: CLARITHROMYCIN PH.EUR 500MG | $136.5K | 3 |
| KLABAX TABLETS 500MG PACK : 14s Strip Batch : DFF2823A, DFF2824A EACH FILM COATED CONTS: CLARITHROMYCIN PH.EUR 500MG | $131.8K | 3 |
| CLARITHROMYCIN BASICS TAB 500MG PACK : 2 | $121.4K | 5 |
| KLABAX TABLETS 500MG PACK : 14S STRIP BATCH : DFF2102A, DFF2103A EACH FILM COATED CONTS: CLARITHROMYCIN PH.EUR 500MG | $102.1K | 3 |
| KLARITHRAN TAB 500 mg 10s SAFR(CLARITHROMYCIN TABLETS)PACK : SP 10s Strip Batch: DFG1621A | $100.0K | 2 |
| CLARITHROMYCIN TABLETS (CLARITHRO SUN PH | $81.4K | 4 |
| KLARITHRAN TAB 500 MG PACK:10S STRIP BATCH:DFE7912A EACH TAB CONTS.CLARITHROMYCIN 500MGNOS | $80.9K | 3 |
| KLABAX TABLETS 250MG PACK : 14s Strip Batch : DFF2707A EACH FILM COATED CONTS: CLARITHROMYCIN PH.EUR 250MG | $67.8K | 3 |
SUN Pharmaceutical Industries Limited exports 235 distinct Clarithromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CLARITHROMYCIN TABLETS 500MG PACK : 2x7 with 6 shipments worth $222.6K.
Regulatory Requirements: Exporting Clarithromycin to Key Markets
What SUN Pharmaceutical Industries Limited must comply with to export Clarithromycin to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Clarithromycin Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $15.4M | 309 | 11 | $50.0K |
| 1 | MICRO LABS LIMITED | $15.4M | 308 | 27 | $50.0K |
| 3 | AUROBINDO PHARMA LTD | $7.8M | 183 | 10 | $42.6K |
SUN Pharmaceutical Industries Limited ranks #2 among 334 Indian Clarithromycin exporters. Average shipment value of $50.0K compared to the market average of $183.3K. The closest competitors by value are MICRO LABS LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Clarithromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 365 | 10.2% |
| DELHI AIR CARGO ACC (INDEL4) | 296 | 8.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 282 | 7.9% |
| DELHI AIR | 258 | 7.2% |
| NHAVA SHEVA SEA (INNSA1) | 229 | 6.4% |
| JNPT/ NHAVA SHEVA SEA | 156 | 4.4% |
| JNPT | 125 | 3.5% |
| DHANNAD ICD | 124 | 3.5% |
What Other Antibiotics Products Does SUN Pharmaceutical Industries Limited Export?
SUN Pharmaceutical Industries Limited also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Clarithromycin Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Clarithromycin, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clarithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clarithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 316 individual customs records matching SUN Pharmaceutical Industries Limited exporting Clarithromycin, covering 235 formulations to 11 countries via 38 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 144+ countries, 811+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clarithromycin Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Clarithromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Clarithromycin Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clarithromycin. For current shipment-level data, contact TransData Nexus.